BioCentury
ARTICLE | Financial News

MacroGenics again amends IPO terms

October 9, 2013 11:42 PM UTC

MacroGenics Inc. (Rockville, Md.) again amended its IPO and said it now plans to sell 5 million shares at $16. With the bumped up number of shares and $16 price, the company would raise $80 million and be valued at $384.3 million. Earlier this month, MacroGenics amended the offering and said it hoped to sell 4 million shares at $14-$16. BofA Merrill Lynch; Leerink; Stifel; Lazard; and Wedbush are underwriters. MacroGenics filed to raise up to $60 million in the IPO in September. ...